BioCentury
ARTICLE | Company News

Noven, Novartis deal

September 8, 2014 7:00 AM UTC

Hisamitsu Pharmaceutical Co. Inc. (Tokyo:4530, Tosu, Japan)and Novartis dissolved Vivelle Ventures LLC, a JV formed in 1998 between Novartis and Hisamitsu's Noven Pharmaceuticals Inc. subsidiary. Novartis said the partners mutually decided to dissolve the JV, which was formed to market Noven's Vivelle estrogen replacement therapy patch in the U.S. Hisamitsu acquired Noven in 2009. ...